With the increasing understanding of tumour immunity, studies have revealed that CD4+ T cells activated only by recognizing MHC class II antigen and activating the immune response of helper T cells play an important role in the antitumour activity of CD8+ effector T cells. Here, CD8A is linked to neoplasm.